Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medivolve Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Cash & Cash Equivalents
CA$806.2k
CAGR 3-Years
-2%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Cash & Cash Equivalents
CA$65.9m
CAGR 3-Years
30%
CAGR 5-Years
6%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Cash & Cash Equivalents
CA$43.4m
CAGR 3-Years
-21%
CAGR 5-Years
80%
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Cash & Cash Equivalents
CA$39m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Cash & Cash Equivalents
CA$1.6m
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Cash & Cash Equivalents
CA$19.2m
CAGR 3-Years
178%
CAGR 5-Years
83%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
806.2k CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Cash & Cash Equivalents amounts to 806.2k CAD.

What is Medivolve Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-29%

Over the last year, the Cash & Cash Equivalents growth was -81%. The average annual Cash & Cash Equivalents growth rates for Medivolve Inc have been -2% over the past three years , -29% over the past five years .

Back to Top